A real‑world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for Paxlovid and Molnupiravir. Human Biology, [S. l.], v. 94, n. 2, p. 572–580, 2024. Disponível em: https://www.humbiol.org/Home/article/view/52.. Acesso em: 21 nov. 2024.